Skip to main content

Table 4 Pre- and post-implantation outcomes stratified by treatment modality employed

From: ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy

  Control Cycles (Pre) Intervention Cycles (Post) OR (95 %CI) Sig (p)
ETs Embryos GSs IR (%) ETs Embryos GSs IR (%)
IVF 75 125 25 20.0 55 79 22 27.8 1.54 (0.8–3.0) 0.196
ICSI 48 87 9 10.3 69 80 15 18.8 2.0 (0.8–4.9) 0.127
FET 30 44 1 2.3 67 96 28 29.2 17.7 (2.3–134.9) 0.006
DE 24 39 3 7.7 60 92 41 44.6 9.6 (2.8–33.6) 0.0004
Overall 177 295 38 12.9 251 347 106 30.5 3.0 (2.0–4.5) 0.0001
  1. Implantation rates (IR) in the studied group of 134 patients, before (Pre) and following (Post) immunomodulatory therapy. Significant improvements seen in IR following immunomodulatory therapy in FET and particularly DE cycles. ETs Embryo transfers, GSs Gestational sacs seen, IVF in-vitro fertilisation cycles, ICSI intracytoplasmic sperm injection cycles, FET Frozen embryo transfer cycles, DE Donor egg cycles
\